DE69635667D1 - Biologisch aktive liganden der eph familie - Google Patents
Biologisch aktive liganden der eph familieInfo
- Publication number
- DE69635667D1 DE69635667D1 DE69635667T DE69635667T DE69635667D1 DE 69635667 D1 DE69635667 D1 DE 69635667D1 DE 69635667 T DE69635667 T DE 69635667T DE 69635667 T DE69635667 T DE 69635667T DE 69635667 D1 DE69635667 D1 DE 69635667D1
- Authority
- DE
- Germany
- Prior art keywords
- biologically active
- active ligands
- eph family
- eph
- ligand
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US701595P | 1995-10-25 | 1995-10-25 | |
US7015P | 1995-10-25 | ||
PCT/US1996/017201 WO1997015667A1 (en) | 1995-10-25 | 1996-10-25 | Biologically active eph family ligands |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69635667D1 true DE69635667D1 (de) | 2006-02-02 |
DE69635667T2 DE69635667T2 (de) | 2006-09-07 |
Family
ID=21723735
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69635667T Expired - Lifetime DE69635667T2 (de) | 1995-10-25 | 1996-10-25 | Biologisch aktive liganden der eph familie |
Country Status (8)
Country | Link |
---|---|
US (2) | US6602683B1 (de) |
EP (1) | EP0859840B1 (de) |
JP (1) | JPH11514238A (de) |
AT (1) | ATE314470T1 (de) |
AU (1) | AU712737B2 (de) |
DE (1) | DE69635667T2 (de) |
IL (1) | IL124202A (de) |
WO (1) | WO1997015667A1 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0842272A4 (de) * | 1995-07-20 | 2002-03-06 | Amrad Operations Pty Ltd | Neuartige rezeptorliganden und genetische sequenzen, welche für diese kodieren |
US6696557B1 (en) * | 1996-04-19 | 2004-02-24 | Genentech, Inc. | AL-2 neurotrophic factor nucleic acid |
EP1141294B1 (de) | 1998-12-23 | 2005-03-02 | Regeneron Pharmaceuticals, Inc. | Methode zur verstärkung der biologischen aktivität von liganden |
EP2096174A1 (de) * | 2008-02-28 | 2009-09-02 | Centro De Investigación Cooperativa En Biociencias CiC bioGune | Ubiquitin-bindende Polypeptide |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3560609B2 (ja) | 1992-11-13 | 2004-09-02 | イミュネックス・コーポレーション | Elkリガンドと呼ばれる新規なサイトカイン |
US6303769B1 (en) * | 1994-07-08 | 2001-10-16 | Immunex Corporation | Lerk-5 dna |
WO1996026958A2 (en) * | 1995-02-27 | 1996-09-06 | President And Fellows Of Harvard College | Eph RECEPTOR LIGAND ELF-2 |
EP0842272A4 (de) * | 1995-07-20 | 2002-03-06 | Amrad Operations Pty Ltd | Neuartige rezeptorliganden und genetische sequenzen, welche für diese kodieren |
KR19990087793A (ko) * | 1996-03-21 | 1999-12-27 | 크리스토퍼 엘. 와이트, 스코트 지. 홀퀴스트, 스티븐 엘. 말라스카 | 러크-8로 표시된 싸이토킨 |
US6696557B1 (en) * | 1996-04-19 | 2004-02-24 | Genentech, Inc. | AL-2 neurotrophic factor nucleic acid |
-
1996
- 1996-10-25 JP JP9516843A patent/JPH11514238A/ja active Pending
- 1996-10-25 AU AU74778/96A patent/AU712737B2/en not_active Ceased
- 1996-10-25 US US09/051,994 patent/US6602683B1/en not_active Expired - Lifetime
- 1996-10-25 WO PCT/US1996/017201 patent/WO1997015667A1/en active IP Right Grant
- 1996-10-25 AT AT96937006T patent/ATE314470T1/de active
- 1996-10-25 DE DE69635667T patent/DE69635667T2/de not_active Expired - Lifetime
- 1996-10-25 EP EP96937006A patent/EP0859840B1/de not_active Expired - Lifetime
-
1998
- 1998-04-23 IL IL124202A patent/IL124202A/en not_active IP Right Cessation
-
2003
- 2003-04-17 US US10/417,924 patent/US20030215918A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1997015667A1 (en) | 1997-05-01 |
DE69635667T2 (de) | 2006-09-07 |
JPH11514238A (ja) | 1999-12-07 |
ATE314470T1 (de) | 2006-01-15 |
AU7477896A (en) | 1997-05-15 |
US6602683B1 (en) | 2003-08-05 |
IL124202A (en) | 2006-06-11 |
US20030215918A1 (en) | 2003-11-20 |
AU712737B2 (en) | 1999-11-11 |
EP0859840B1 (de) | 2005-12-28 |
EP0859840A1 (de) | 1998-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0669929T3 (da) | Elk-ligand, et cytokin | |
DK0758383T3 (da) | Oplöselige polypeptidfraktioner af LAG-3-proteinet; fremgangsmåde til fremstilling; terapeutisk sammensætning; antiidiotypisk antistof | |
DE68929402D1 (de) | Verfahren zur herstellung von wasserlöslichen polypeptiden | |
ATE232901T1 (de) | Biologisch aktive ligande der eph familie | |
ATE324441T1 (de) | Htk-ligand | |
DK0760857T5 (da) | Receptor for onkostatin M | |
FI104180B1 (fi) | Menetelmä polypeptidin vasta-aineen ekä IL-4 välittämien tilojen hoitoon tarkoitetun seoksen valmistamiseksi | |
ATE456654T1 (de) | Löslicher zytokinrezeptor zalpfa11 | |
DK624884A (da) | Peptider | |
WO2002012345A3 (en) | Soluble zcytor 11 cytokine receptors | |
CA2011450A1 (en) | Recombinant b-chain of the il-2 receptor | |
ATE212059T1 (de) | Methoden zur identifizierung heterofunktionaler fusionsproteine | |
DE3582895D1 (de) | Peptid, dessen herstellung und benutzung. | |
PL349158A1 (en) | Method of enhancing the biological activity of ligands | |
ATE314470T1 (de) | Biologisch aktive liganden der eph familie | |
DE69935782D1 (de) | Brustkrebsresistenzprotein (bcrp) und für dieses kodierende dna | |
KR930701487A (ko) | 식물성 독소 겔로닌의 단백질 구조물 | |
DK0656117T3 (da) | Fremgangsmåde til udvælgelse af superagonister, antagonister og superantagonister for interleukin 6 | |
CA2236001A1 (en) | Biologically active eph family ligands | |
DE3856069D1 (de) | Cdna, die für peptidyl-glycin alphaamidierende monooxygenase (pam) codiert | |
DE59911530D1 (de) | Zellpermeabilität-vermittelndes polypeptid | |
ATE386114T1 (de) | Gene, die für lymphocyte spezifischen interferon- regulationsfaktor (lsirf) polypeptide kodiert | |
ES2033212A6 (es) | Procedimiento para la obtencion de peptidos puramente glicosilados, parcialmente glicosilados o no glicosilados. | |
EP1736545A3 (de) | Lösliche Zcyctor 11 Cytokinrezeptoren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |